Target intelligence / Profile preview

Sinoatrial node cell excitability (SA node cell excitability)

Target
SA node cell excitability
Molecular classification
Other (specialized cardiac myocyte), Ion channel-expressing cell (expresses multiple ion channels and receptors associated with cardiac automaticity)
01

Overview

Sinoatrial node cell excitability refers to the ability of pacemaker cells within the sinoatrial node to generate spontaneous action potentials that set the heart’s rhythm and rate. This property is determined by the activity of various ion channels—including hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, voltage-gated calcium channels (Cav), sodium channels, and potassium channels—as well as by the influence of the autonomic nervous system. The coordinated function of these channels underlies the unique automaticity of SA node cells, enabling them to serve as the primary pacemaker of the heart. Abnormal excitability of these cells leads to clinical conditions such as sinus node dysfunction and other arrhythmias. Therapies that target specific aspects of SA node cell excitability (e.g., HCN4 inhibition by Ivabradine) are used to manage heart rate in certain cardiovascular conditions, but non-specific modulation can carry significant safety concerns, including bradycardia and possible heart block.

Other names
SA node cellSAN cellpacemaker cell (of the heart)sinus node cell
02

Mechanism of action

Inhibition or modulation of HCN channel-mediated currents (e.g., Ivabradine blocks I_f current via HCN4 channels); Modulation of sympathetic or parasympathetic control (e.g., beta blockers, muscarinic agonists); Alteration of Ca2+ channel currents (various drugs)

03

Biological functions

Pacemaking (generation of spontaneous action potentials)Regulation of cardiac rhythmInitiation of electrical conduction in the heart
04

Disease associations

Cardiovascular diseaseArrhythmia (especially sinus node dysfunction and sick sinus syndrome)
05

Safety considerations

Excessive inhibition can cause bradycardia, sinus arrest, or heart blockPro-arrhythmic risk from non-specific modulation of cellular excitabilityPotential for negative inotropic effects or exacerbation of heart failure with incorrect pharmacological modulation
06

Interacting drugs

Ivabradine

3 more in the full profile.

07

Biomarkers

HCN4 protein expression (used as a biomarker for pacemaker cells)Molecular markers: TBX3, TBX5, TBX18, SHOX2, ISL1 (transcription factors in SAN development)

Beyond the preview

Go deeper on Sinoatrial node cell excitability (SA node cell excitability).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinoatrial node cell excitability (SA node cell excitability).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call